Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 25297-52-3 | MDL No. : | MFCD16610595 |
Formula : | C7H8ClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | VZSDUELFJLOABU-UHFFFAOYSA-N |
M.W : | 157.60 | Pubchem ID : | 57906710 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.29 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 40.71 |
TPSA : | 22.12 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.5 cm/s |
Log Po/w (iLOGP) : | 2.37 |
Log Po/w (XLOGP3) : | 2.48 |
Log Po/w (WLOGP) : | 2.05 |
Log Po/w (MLOGP) : | 1.49 |
Log Po/w (SILICOS-IT) : | 2.42 |
Consensus Log Po/w : | 2.16 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.76 |
Solubility : | 0.275 mg/ml ; 0.00175 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.59 |
Solubility : | 0.406 mg/ml ; 0.00258 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.14 |
Solubility : | 0.114 mg/ml ; 0.000721 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.8 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H227-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
61% | Stage #2: for 48 h; Reflux |
Reference Example 53; 2-chloro-6-methoxy-4-methyl-pyridine; A solution of 2,6-dichloro-4-methyl-pyridine (250 mg, 1.5 mmol) in methanol (2 mL) was added to a solution of sodium methoxide (prepared from sodium (71 mg, 3.0 mmol) and anhydrous methanol (20 mL)) and heated at reflux for 48 h. The solvent was evaporated and the residue partitioned between water and dichloromethane. The organic layer was separated, washed with water, brine, dried over anhydrous sodium sulfate and concentrated to afford 2-chloro-6-methoxy-4-methyl-pyridine (150 mg, 61percent) as a pale orange oily liquid. |
[ 193001-91-1 ]
(2-Chloro-6-methoxypyridin-4-yl)methanol
Similarity: 0.92
[ 1256788-36-9 ]
2-Chloro-6-methoxyisonicotinonitrile
Similarity: 0.89
[ 1160994-99-9 ]
2-Chloro-6-methoxy-4-(trifluoromethyl)pyridine
Similarity: 0.82
[ 95652-81-6 ]
6-Chloro-2-methoxynicotinaldehyde
Similarity: 0.82
[ 121643-46-7 ]
6-Chloro-2-methoxynicotinonitrile
Similarity: 0.82
[ 193001-91-1 ]
(2-Chloro-6-methoxypyridin-4-yl)methanol
Similarity: 0.92
[ 1256788-36-9 ]
2-Chloro-6-methoxyisonicotinonitrile
Similarity: 0.89
[ 1160994-99-9 ]
2-Chloro-6-methoxy-4-(trifluoromethyl)pyridine
Similarity: 0.82
[ 95652-81-6 ]
6-Chloro-2-methoxynicotinaldehyde
Similarity: 0.82
[ 121643-46-7 ]
6-Chloro-2-methoxynicotinonitrile
Similarity: 0.82
[ 193001-91-1 ]
(2-Chloro-6-methoxypyridin-4-yl)methanol
Similarity: 0.92
[ 1256788-36-9 ]
2-Chloro-6-methoxyisonicotinonitrile
Similarity: 0.89
[ 1160994-99-9 ]
2-Chloro-6-methoxy-4-(trifluoromethyl)pyridine
Similarity: 0.82
[ 95652-81-6 ]
6-Chloro-2-methoxynicotinaldehyde
Similarity: 0.82
[ 121643-46-7 ]
6-Chloro-2-methoxynicotinonitrile
Similarity: 0.82